Christina H. Ruhlmann

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

Fausto Roila, Alex Molassiotis, Jørn Herrstedt et al. · Annals of Oncology · 2016 · 580 citations · Full text

Medicine, Oncology, Radiation Oncology +14

2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

Jørn Herrstedt, Rebecca Clark-Snow, Christina H. Ruhlmann et al. · ESMO Open · 2024 · 141 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial

Christina H. Ruhlmann, Line Hammer Dohn, Merete Paludan et al. · The Lancet Oncology · 2016 · 47 citations

Medicine, Oncology, Pharmacology +13

The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients

Inge Marie Svane, Henrik Schmidt, Charlotte Aaquist Haslund et al. · Cancer Epidemiology · 2021 · 43 citations · Full text

Medicine, Biomedical Informatics, Oncology +17

Multinational study exploring patients’ perceptions of side-effects induced by chemo-radiotherapy

Christina H. Ruhlmann, Trine Zeeberg Iversen, Meena Okera et al. · Radiotherapy and Oncology · 2015 · 30 citations

Medicine, Oncology, Radiation Oncology +14